Literature DB >> 33224827

Postoperative complications and quality of life in patients with pituitary adenoma.

Jiajia Zhang1, Ya Wang1, Xiuqun Xu2, Yudan Gu1, Fei Huang1, Min Zhang1.   

Abstract

BACKGROUND: Pituitary adenomas (PAs) are tumors that arise from the cells of the anterior pituitary gland. PAs are the most common tumors to occur in the sella area and the third most common intracranial neoplasm in surgery. Due to developments such as microscopy and neuroendoscopy, the curative effect of PA surgery continues to improve. However, postoperative complications may still occur. PA surgery can result in iatrogenic trauma, which is a primary cause of cerebrospinal fluid (CSF) rhinorrhea. PA surgery can affect the posterior pituitary gland, causing decreased antidiuretic hormone secretion and increased urine output, which can lead to hyponatremia. The nasal cavity and sphenoid sinuses may also be damaged during PA surgery, causing the sphenoethmoidal recess to be blocked. This increases the risk of infection. The purpose of this study was to analyze quality of life in PA patients post-resection, and to provide references for the development of early targeted risk assessment programs and intervention measures.
METHODS: We selected patients who underwent neuroendoscopic transnasal PA resection at the Affiliated Hospital of Nantong University between January 2017 and October 2019. These patients' hospital records were retrospectively obtained, including details of any postoperative complications. The patients were followed up by telephone 12 weeks following discharge, and we used the EuroQol 5 Dimensions (EQ-5D) health scale to assess the patients' quality of life.
RESULTS: At follow-up 3 months after discharge, 68 people (41.72%) had experienced at least one common complication, including 7 cases of infection (4.29%), 56 cases of hypopituitarism (34.36%), 18 cases of CSF rhinorrhea (11.04%), 28 cases of diabetes insipidus (17.18%), and 25 cases of hyponatremia (15.34%). Patients that experienced complications reported having more serious problems on the dimensions of the EQ-5D descriptive system (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) than patients without complications. The scores of patients with complications on the EQ-5D visual analog scale (EQ-VAS) were lower than that of patients without complications.
CONCLUSIONS: Postoperative complications are negatively associated with quality of life in PA patients. Actively preventing common complications could therefore improve these patients' quality of life and reduce their burden of disease. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  EQ-5D visual analog scale (EQ-VAS); EuroQol 5 Dimensions (EQ-5D); Pituitary adenoma (PA); complication; nursing care; quality of life

Year:  2020        PMID: 33224827      PMCID: PMC7667121          DOI: 10.21037/gs-20-690

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  15 in total

1.  Living with a pituitary tumour: a narrative analysis.

Authors:  Jane Simpson; James Heath; Gemma Wall
Journal:  Psychol Health       Date:  2013-09-27

Review 2.  Psychosocial environmental factors and psychosocially mediated effects of physical environmental factors.

Authors:  L Levi
Journal:  Scand J Work Environ Health       Date:  1997       Impact factor: 5.024

3.  Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea.

Authors:  Seon Ha Kim; Hwa Jung Kim; Sang-Il Lee; Min-Woo Jo
Journal:  Qual Life Res       Date:  2011-09-23       Impact factor: 4.147

4.  Health-related quality of life and psychiatric symptoms improve effectively within a short time in patients surgically treated for pituitary tumors--a longitudinal study of 106 patients.

Authors:  Monika Milian; Juergen Honegger; Christine Gerlach; Tsambika Psaras
Journal:  Acta Neurochir (Wien)       Date:  2013-07-09       Impact factor: 2.216

5.  Pituitary tumors: coping with ‘cured’ pituitary tumors.

Authors:  Susan M Webb
Journal:  Nat Rev Endocrinol       Date:  2011-05       Impact factor: 43.330

Review 6.  Management of pituitary tumors.

Authors:  I Shimon; S Melmed
Journal:  Ann Intern Med       Date:  1998-09-15       Impact factor: 25.391

7.  Validity and reliability of the EQ-5D for cancer patients in Korea.

Authors:  Seon Ha Kim; Jung Sung Hwang; Tae Won Kim; Yong Sang Hong; Min-Woo Jo
Journal:  Support Care Cancer       Date:  2012-04-10       Impact factor: 3.603

Review 8.  Molecular and trophic mechanisms of tumorigenesis.

Authors:  Andy Levy
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

Review 9.  Pituitary adenomas: historical perspective, surgical management and future directions.

Authors:  Debebe Theodros; Mira Patel; Jacob Ruzevick; Michael Lim; Chetan Bettegowda
Journal:  CNS Oncol       Date:  2015-10-26

10.  The role of multimodal navigation in endoscopic endonasal surgery for giant pituitary adenomas.

Authors:  Chen Yang; Jiarui Zhang; Jianzhong Li; Nan Wu; Dong Jia
Journal:  Gland Surg       Date:  2019-12
View more
  4 in total

1.  Novel Nomograms to Predict Delayed Hyponatremia After Transsphenoidal Surgery for Pituitary Adenoma.

Authors:  Kunzhe Lin; Ran Zeng; Shuwen Mu; Yinghong Lin; Shousen Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

Review 2.  Acromegaly and male sexual health.

Authors:  Gianmaria Salvio; Marianna Martino; Giancarlo Balercia; Giorgio Arnaldi
Journal:  Rev Endocr Metab Disord       Date:  2022-04-01       Impact factor: 9.306

3.  Risk factors and management associated with postoperative cerebrospinal fluid leak after endoscopic endonasal surgery for pituitary adenoma.

Authors:  Bin Li; Sida Zhao; Qiuyue Fang; Ding Nie; Jianhua Cheng; Haibo Zhu; Chuzhong Li; Songbai Gui; Yazhuo Zhang; Peng Zhao
Journal:  Front Surg       Date:  2022-09-07

4.  Diaphragma sellae sinking can predict the onset of hyponatremia after transsphenoidal surgery for pituitary adenomas.

Authors:  Kunzhe Lin; Jun Li; Lingling Lu; Shangming Zhang; Shuwen Mu; Zhijie Pei; Cheng Wang; Jingying Lin; Liang Xue; Liangfeng Wei; Lin Zhao; Shousen Wang
Journal:  J Endocrinol Invest       Date:  2021-06-14       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.